|
Marsh, Sharon; King, Cristi R; Van Booven, Derek J et al. (2015) Pharmacogenomic assessment of Mexican and Peruvian populations. Pharmacogenomics 16:441-8
|
|
Patel, Jai N; Jiang, Chen; Hertz, Daniel L et al. (2015) Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance). Cancer 121:1025-31
|
|
Hariani, Gunjan D; Lam, Ernest T; Lam, Ernest J et al. (2014) Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics. BMC Res Notes 7:360
|
|
McWhinney-Glass, Sarah; Winham, Stacey J; Hertz, Daniel L et al. (2013) Cumulative genetic risk predicts platinum/taxane-induced neurotoxicity. Clin Cancer Res 19:5769-76
|
|
Trammel, Morgan; Roederer, Mary; Patel, Jai et al. (2013) Does pharmacogenomics account for variability in control of acute chemotherapy-induced nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists? Curr Oncol Rep 15:276-85
|
|
Motsinger-Reif, Alison A; Jorgenson, Eric; Relling, Mary V et al. (2013) Genome-wide association studies in pharmacogenomics: successes and lessons. Pharmacogenet Genomics 23:383-94
|
|
Crowley, James J; Kim, Yunjung; Szatkiewicz, Jin Peng et al. (2012) Genome-wide association mapping of loci for antipsychotic-induced extrapyramidal symptoms in mice. Mamm Genome 23:322-35
|
|
He, Y J; McLeod, H L (2012) Ready when you are: easing into preemptive pharmacogenetics. Clin Pharmacol Ther 92:412-4
|
|
Hoskins, Janelle M; Ong, Pei-Shi; Keku, Temitope O et al. (2012) Association of eleven common, low-penetrance colorectal cancer susceptibility genetic variants at six risk loci with clinical outcome. PLoS One 7:e41954
|
|
Crowley, J J; Adkins, D E; Pratt, A L et al. (2012) Antipsychotic-induced vacuous chewing movements and extrapyramidal side effects are highly heritable in mice. Pharmacogenomics J 12:147-55
|
Showing the most recent 10 out of 181 publications
